The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms
Deisseroth, A.; Abrams, R.A.
Cancer Treatment Reports 63(3): 461-471
1979
ISSN/ISBN: 0361-5960 PMID: 371800 Document Number: 151058
A review was presented of the use of cryopreserved autologous bone marrow cells to protect cancer patients against the hematologically lethal effects of radiotherapy and intensive chemotherapy. Topics discussed included technical aspects of cryopreservation, use of animal models and clinical studies in man.
Document emailed within 1 workday
Related Documents
Kotasek, D.; Sage, R.E.; Dale, B.M.; Norman, J.E.; Bolton, A. 1994: Dose intensive therapy with autologous blood stem cell transplantation in breast cancer Australian and New Zealand Journal of Medicine 24(3): 288-295Guillaume, T.; Sekhavat, M.; Rubinstein, D.B.; Hamdan, O.; Leblanc, P.; Symann, M.L. 1994: Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 54(14): 3800-3807
de Witte, T.; Brand, R.; van Biezen, A.; Delforge, M.; Biersack, H.; Or, R.; Meloni, G.; Bandini, B.; Sierra, J.; Kroger, N.; Gratwohl, A.; Niederwieser, D. 2006: The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes Haematologica 91(6): 750-756
Voorhees, P.M.; Usmani, S.Z. 2016: The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy Clinical Advances in Hematology and Oncology: H&o 14(9): 719-728
Wang, W.J.; Dong, L.H.; Du, J.W. 2017: A case report: chemotherapy combined with autologous hematopoietic stem cell transplantation in treatment of blastie plasmacytoid dendritic cell neoplasms Zhonghua Nei Ke Za Zhi 56(2): 131-132
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
van Laar, J.M.; Verburg, R.J.; Fibbe, W.E.; Breedveld, F.C. 2001: Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience Journal of Rheumatology. Supplement 64: 25-27
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376
Harousseau, J.L.; Attal, M. 1997: The role of autologous hematopoietic stem cell transplantation in multiple myeloma Seminars in Hematology 34(1 Suppl 1: 61-66
Papajik, T.; Raida, L.; Faber, E.; Vondrakova, J.; Prochazka, V.; Kubova, Z.; Skoumalova, I.; Jarosova, M.; M, L.K.; Paucek, B.; Myslivecek, M.; Neoral, C.; Oral, I.; Jarkovsky, J.; Dusek, L.; Indrak, K. 2008: High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission Neoplasma 55(3): 215-221
Siena, S.; Bregni, M.; Di Nicola, M.; Magni, M.; Ravagnani, F.; Gandola, L.; Lombardi, F.; Gianni, A.M. 1996: Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation Tumori 82(2 Suppl): S23-S27
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Franzius, C.; Bielack, S.; Flege, S.; Eckardt, J.; Sciuk, J.; Jürgens, H.; Schober, O. 2001: High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma NUKLEARMEDIZIN. Nuclear Medicine 40(6): 215-220
Lakota, J.; Fuchsberger, P. 1996: Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO Bone Marrow Transplantation 18(1): 262-263
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
To, L.B.; Juttner, C.A.; Stomski, F.; Vadas, M.A.; Kimber, R.J. 1987: Immune reconstitution following peripheral blood stem cell autografting Bone Marrow Transplantation 2(1): 111-112
Ljungman, P. 1998: Immune reconstitution and viral infections after stem cell transplantation Bone Marrow Transplantation 21(Suppl 2): S72-S74
de Graaf, H.; Mulder, N.H.; Willemse, P.H.; van der Graaf, W.T.; Sleijfer, D.T.; Zijlstra, J.G.; Elias, M.; Sibinga, C.T.; Vellenga, E.; de Vries, E.G. 1995: The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease Anticancer Research 15(6B): 2851-2856
Da, W.M. 1987: Intensive chemoradiotherapy and autologous bone marrow transplantation for resistant lymphoma Bone Marrow Transplantation 2(1): 112-113
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654